Idera Pharmaceuticals Inc. (IDRA) had a good day on the market for Tuesday April 02 as shares jumped 5.41% to close at $2.73. About 554,968 shares traded hands on 2,223 trades for the day, compared with an average daily volume of n/a shares out of a total float of 27.62 million. After opening the trading day at $2.58, shares of Idera Pharmaceuticals Inc. stayed within a range of $2.85 to $2.58.
With today’s gains, Idera Pharmaceuticals Inc. now has a market cap of $75.4 million. Shares of Idera Pharmaceuticals Inc. have been trading within a range of $17.12 and $2.25 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates. The 3GA technology is used to create drug candidates to turn off the RNA messengers associated with genes causing various diseases.
Idera Pharmaceuticals Inc. is based out of Exton, PA and has some 36 employees.